Both optical coherence tomography (OCT) and autofluorescence imaging (AFI) have shown potential for cancer detection. OCT is able to measure epithelial thickness and identify micro invasion through the basement membrane. AFI in the lung and oral cavity is used clinically to identify abnormal tissue and guide biopsy site selection. Recently, we demonstrated the ability of catheter-based AFI to identify vascular networks in small peripheral airways.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.